Effect of Selective Inhibition of Soluble Guanylyl Cyclase on the KCa Channel Activity in Coronary Artery Smooth Muscle

Hypertension

Volumn 31, Issue 1, 1998, Pages 303-308

  Li, Pin Lan ^a   Jin, Man Wen ^a   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC GMP; GUANYLATE CYCLASE; POTASSIUM CHANNEL; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; 2,2' (HYDROXYNITROSOHYDRAZONO)BIS ETHANAMINE; 2,2'-(HYDROXYNITROSOHYDRAZONO)BIS-ETHANAMINE; 8-BROMOCYCLIC GMP; ADENOSINE; CYCLIC GMP; DRUG DERIVATIVE; ENZYME INHIBITOR; IBERIOTOXIN; ILOPROST; NITROSO DERIVATIVE; OXADIAZOLE DERIVATIVE; PEPTIDE; QUINOXALINE DERIVATIVE; SCORPION VENOM;

ARTERY MUSCLE; ARTICLE; CONCENTRATION RESPONSE; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; VASODILATATION; ANIMAL; CATTLE; CELL MEMBRANE POTENTIAL; CORONARY BLOOD VESSEL; DRUG ANTAGONISM; IN VITRO STUDY; KINETICS; MUSCLE CONTRACTION; PATCH CLAMP; PHYSIOLOGY;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADENOSINE; ANIMALS; CATTLE; CORONARY VESSELS; CYCLIC GMP; ENZYME INHIBITORS; GUANYLATE CYCLASE; ILOPROST; KINETICS; MEMBRANE POTENTIALS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITROSO COMPOUNDS; OXADIAZOLES; PATCH-CLAMP TECHNIQUES; PEPTIDES; POTASSIUM CHANNELS; QUINOXALINES; SCORPION VENOMS; VASODILATION;

EID: 0031911336     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.303     Document Type: Article

References (31)

1. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
2. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
3. Nelson MT, Quayle JM. Physiological role and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799-C822.
4. Robertson BE, Schubert R, Hescheler J, Nelson MT. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol. 1993;265:C299-C303.
5. + channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pflugers Arch. 1993;463:167-172.
6. Li PL, Zou AP, Campbell WB. Regulation of potassium channels in coronary smooth muscle by endothelium-derived vasodilators. Hypertension. 1997;29:262-267.
7. Drewett JG, Garbers DL. The family of guanylyl cyclase-receptors, their ligands and functions. Endocr Rev. 1994;15:135-162.
8. Cohen RA, Vanhoutte PM, Endothelium-dependent hyperpolarization beyond nitric oxide and cyclic GMP. Circulation. 1995;92:3337-3349.
9. Nakatsu K, Diamond J. Role of cGMP in the relaxation of vascular and other smooth muscle. Can J Physiol Pharmacol. 1989;67:251-262.
10. Waldman SA, Murad F, Cyclic GMP synthesis and function. Pharmacol Rev. 1987;39:163-196.
11. Diamond J. Effects of LY83583, nordihydroguaiaretic acid, and quinacrine on cyclic GMP elevation and inhibition of tension by muscarinic agonists in rabbit aorta and left atrium. Can J Physiol Pharmacol. 1987;65:1913-1917.
12. Malta E, Macdonald PS, Dusting GJ. Inhibition of vascular smooth muscle relaxation by LY83583. Naunyn Schmiedebergs Arch Pharmacol. 1988;337:459-464.
13. Isono T, Koibuchi Y, Sara N, Furuichi A, Nishii M, Yamamoto T, Mori J, Kohsaka M, Ohtsuka M. Vasorelaxant mechanism of the new vasodilator, FK409. Eur J Pharmacol. 1993;246:205-212.
14. Luo D, Das S, Vincent SR. Effect of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. Eur J Pharmacol. 1995;290:247-251.
15. Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol. 1993;45:367-374.
16. Brune B, Schmidt KU, Ulrich V. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem. 1990;192:683-688.
17. Wolin MS, Cherry PD, Rodenburg JM, Messina EJ, Kaley G, Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther. 1990;254:872-876.
18. Mulsch A, Busse R, Liebau S, Forstermann U. LY83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J Pharmacol Exp Ther. 1985;232:764-769.
19. Cherry PD, Omar HA, Farrell KA, Stuart JS, Wolin MS. Superoxide anion inhibits cGMP-associated bovine pulmonary arterial relaxation. Am J Physiol. 1990;25:H1056-H1062.
20. Olson LJ, Knych Jr ET, Herzig TC, Drewett JG. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation. Hypertension. 1997;29:254-261.
21. +) channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ Res. 1997;80:877-884.
22. Rosolowsky M, Campbell WB. Role of PGI2 and EETs in the relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol. 1993;264:H327-H335.
23. Pratt PF, Rosolowsky M, Campbell WB. Mediators of arachidonic acid-induced relaxation of bovine coronary artery. Hypertension. 1996;28:76-82.
24. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1994;91:7583-7587.
25. Kannan MS, Johnson DE. Modulation of nitric oxide-dependent relaxation of pig tracheal smooth muscle by inhibitors of guanylyl cyclase and calcium activated potassium channels. Life Sci. 1995;56:2229-2238.
26. + channels in pulmonary vascular smooth muscle cells: role of nitric oxide. J Appl Physiol. 1996;81:1264-1272.
27. + channels in porcine tracheal smooth muscle cells. Am J Physiol. 1996;270:L338-L345.
28. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels and voltage-dependence of arterial smooth muscle cell tone. Am J Physiol. 1990;259:C3-C18.
29. Toro L, Amador M, Stefani E. ANG II inhibits calcium-activated potassium channels from coronary smooth muscle in lipid bilayers. Am J Physiol. 1990;258:H912-H915.
30. Campbell WB, Gebremadhin D, Pratt P, Harder DR. Identification of epoxyeicosatrienoic acid as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423.
31. Sadoshima J, Akaike N, Kanaide H, Nakamura M. Cyclic AMP modulates Ca-activated K channel in cultured smooth muscle cells of rat aortas. Am J Physiol. 1988;255:H754-H7.